Understanding CGM-A1c Discordance: Why Your Glucose Readings and A1c Might Not Match

For millions of people managing diabetes, the Hemoglobin A1c (HbA1c) test has long been the gold standard for measuring long-term glycemic control. However, the rise of Continuous Glucose Monitoring (CGM) technology has revealed a common source of frustration: the “A1c-CGM discordance.” This occurs when a patient’s estimated A1c from their CGM device significantly differs from the laboratory-measured HbA1c.

As a clinician, I frequently encounter patients concerned that their devices are malfunctioning when these numbers don’t align. Understanding why this happens requires looking beyond the surface of the numbers to the physiological drivers of glucose variability.

What is CGM-A1c Discordance?

The HbA1c test measures the percentage of hemoglobin that has been glycated—or coated with sugar—over the previous two to three months. It essentially provides a weighted average of your blood glucose levels. A CGM, conversely, provides real-time, interstitial glucose readings every few minutes, offering a high-resolution view of your glycemic landscape.

Discordance occurs when the “Glucose Management Indicator” (GMI), which is the CGM’s estimate of your A1c based on average sensor glucose, does not match the laboratory-verified HbA1c. While some variation is expected, significant discrepancies often point to specific biological factors that influence how sugar interacts with your red blood cells.

The Role of Glucose Excursions

Research published in journals like Diabetes Care suggests that the frequency and magnitude of glucose excursions—the spikes and dips in your blood sugar—play a major role in this mismatch. While the A1c is an average, it is not a perfect summary of glycemic stability.

Two patients can have the same average glucose level, but different A1c results. This is often due to the “glycemic variability” factor. If a patient experiences frequent, rapid spikes (hyperglycemic excursions) followed by sharp drops, the biochemical process of glycation may occur at a different rate than in a patient with a stable, flat glucose profile, even if their mathematical averages are identical.

Biological Factors Beyond Glucose

It is crucial to recognize that the HbA1c test is a biological measurement, not a purely mathematical one. Several factors can skew the results:

• Red Blood Cell Lifespan: HbA1c relies on the lifespan of red blood cells (typically 90 to 120 days). Conditions like anemia, iron deficiency, or hemolytic disorders can shorten this lifespan, leading to a falsely low A1c because there is less time for glycation to occur.
• Hemoglobin Variants: Genetic variations in hemoglobin (such as sickle cell trait) can interfere with the assay methods used in labs, leading to inaccurate readings.
• Kidney Function: Chronic kidney disease can alter the accuracy of A1c testing, often requiring clinicians to rely more heavily on CGM data for management.

Key Takeaways for Patients

If you notice a discrepancy between your CGM data and your lab-based A1c, do not panic. Consider these points:

• Focus on Time in Range (TIR): Rather than obsessing over a single A1c number, modern diabetes management emphasizes Time in Range—the percentage of time your glucose stays within your target goal (usually 70–180 mg/dL).
• Consult Your Physician: If the discordance is persistent, your doctor may order a fructosamine test, which measures blood sugar control over a shorter, two-to-three-week period, to help clarify the picture.
• Acknowledge the Limitation: Remember that A1c is a population-based metric. Your CGM data provides a personalized, real-time look at your specific metabolic needs.

Moving Forward with Personalized Care

The clinical utility of CGM technology lies in its ability to show us the “hidden” spikes that A1c misses. While the A1c remains a valuable clinical tool for assessing long-term risk of complications, it is best viewed as one piece of a larger puzzle. By combining the historical view provided by the A1c with the granular, actionable data from your CGM, you and your healthcare team can create a more effective, personalized strategy for your health.

If you are experiencing significant gaps between your GMI and A1c, discuss these trends with your endocrinologist. Often, the solution is not to distrust your technology, but to better interpret the biological variability that makes your metabolic profile unique.

Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.